Related Experiment Videos
[CA19-9-producing testicular tumor: a case report]
M Minamide1, I Hosoi, S Yanagi
1Department of Urology, Chiba Rousai Hospital.
Hinyokika Kiyo. Acta Urologica Japonica
|March 21, 2000
Summary
This report details a rare CA19-9-producing testicular tumor in a 37-year-old male. Successful treatment involved surgery and chemotherapy, leading to an 18-month recurrence-free survival.
Area of Science:
- Oncology
- Pathology
Background:
- Testicular tumors are rare malignancies.
- Elevated cancer antigen 19-9 (CA19-9) is typically associated with gastrointestinal and pancreatic cancers.
Observation:
- A 37-year-old male presented with fever and right scrotal swelling.
- Imaging revealed a right testicular tumor with lung and lymph node metastases.
- Histopathology confirmed a mixed germ cell tumor: teratoma, yolk sac tumor, embryonal carcinoma, and seminoma.
Findings:
- Immunohistochemical analysis demonstrated CA19-9 expression in the tumor cells.
- Post-orchiectomy and chemotherapy, the patient's CA19-9 levels normalized within four weeks.
- The patient achieved 18 months of recurrence-free survival after lung metastasis resection.
Implications:
- This case highlights the potential for CA19-9 production in rare testicular germ cell tumors.
- CA19-9 may serve as a potential tumor marker in specific testicular cancer subtypes.
- Multimodality treatment including chemotherapy and surgery can be effective for metastatic testicular germ cell tumors.